AusPAR: Ryaltris

Australian Public Assessment Report

AusPAR

AusPAR: Ryaltris [PDF, 1.16 MB]

AusPAR: Ryaltris [Word, 4.25 MB]

AusPAR Attachment 1: Product Information for Ryaltris [PDF, 406.92 KB]

AusPAR Attachment 1: Product Information for Ryaltris [Word, 558.19 KB]

Device/Product Name

Ryaltris

Active ingredients

Olopatadine / mometasone furoate

AusPAR Date

17 March 2023

Published

23 March 2023

Submission Number

PM-2020-06532-1

Submission Type

Extension of indications

Decision

Approved